An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study to compare two manufacturing processes for levonorgestrel 90 mg/ethinyl estradiol 20 mg (LNG/EE) in healthy, cycling women.

Trial Profile

An open-label, single-dose, randomized, 2-period, crossover, bioequivalence study to compare two manufacturing processes for levonorgestrel 90 mg/ethinyl estradiol 20 mg (LNG/EE) in healthy, cycling women.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Aug 2009

At a glance

  • Drugs Ethinylestradiol/levonorgestrel (Primary)
  • Indications Premenstrual dysphoric disorder
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 11 Aug 2009 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
    • 27 Feb 2007 Status changed from in progress
    • 12 Dec 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top